Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA

Chang Yingjun · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
transplantation candidates with hematological diseases, donor-specific antibody (dsa) ≥5000 mfi, cd19-bcma dual nanobody based car-t cells, patients with hematological diseases, allogeneic hematopoietic stem cell transplantation, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873668
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.